JAGIELSKA , B.; CZUBEK, A.; TALASIEWICZ , K.; TWAROWSKI , A.; RUTKOWSKI , P.; KRZAKOWSKI , M.; SAETRE , B.; MALECKI , M. Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS) . Molecular Cellular Therapy and Mechanism, [S. l.], v. 6, n. 1, p. 37–49, 2023. Disponível em: https://journal.riverpublishers.com/index.php/MCTM/article/view/211. Acesso em: 27 jul. 2024.